These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 27765751)
1. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators. Fiorucci S; Zampella A; Cirino G; Bucci M; Distrutti E Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H21-H32. PubMed ID: 27765751 [TBL] [Abstract][Full Text] [Related]
2. Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids. Renga B; Bucci M; Cipriani S; Carino A; Monti MC; Zampella A; Gargiulo A; d'Emmanuele di Villa Bianca R; Distrutti E; Fiorucci S Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H114-26. PubMed ID: 25934094 [TBL] [Abstract][Full Text] [Related]
3. Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension. Fiorucci S; Distrutti E Pharmacol Res; 2016 Sep; 111():749-756. PubMed ID: 27475883 [TBL] [Abstract][Full Text] [Related]
4. Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1. Renga B; Cipriani S; Carino A; Simonetti M; Zampella A; Fiorucci S PLoS One; 2015; 10(11):e0141082. PubMed ID: 26539823 [TBL] [Abstract][Full Text] [Related]
5. Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. Renga B; Mencarelli A; Migliorati M; Distrutti E; Fiorucci S World J Gastroenterol; 2009 May; 15(17):2097-108. PubMed ID: 19418582 [TBL] [Abstract][Full Text] [Related]
6. Investigation on bile acid receptor regulators. Discovery of cholanoic acid derivatives with dual G-protein coupled bile acid receptor 1 (GPBAR1) antagonistic and farnesoid X receptor (FXR) modulatory activity. Sepe V; Renga B; Festa C; Finamore C; Masullo D; Carino A; Cipriani S; Distrutti E; Fiorucci S; Zampella A Steroids; 2016 Jan; 105():59-67. PubMed ID: 26607331 [TBL] [Abstract][Full Text] [Related]
7. The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver. Klindt C; Reich M; Hellwig B; Stindt J; Rahnenführer J; Hengstler JG; Köhrer K; Schoonjans K; Häussinger D; Keitel V Cells; 2019 Nov; 8(11):. PubMed ID: 31752395 [TBL] [Abstract][Full Text] [Related]
8. The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy. Carino A; Marchianò S; Biagioli M; Scarpelli P; Bordoni M; Di Giorgio C; Roselli R; Fiorucci C; Monti MC; Distrutti E; Zampella A; Fiorucci S FASEB J; 2021 Jan; 35(1):e21271. PubMed ID: 33368684 [TBL] [Abstract][Full Text] [Related]
9. Vasodilator effects of sulforaphane in cerebral circulation: A critical role of endogenously produced hydrogen sulfide and arteriolar smooth muscle K Parfenova H; Liu J; Hoover DT; Fedinec AL J Cereb Blood Flow Metab; 2020 Oct; 40(10):1987-1996. PubMed ID: 31594422 [TBL] [Abstract][Full Text] [Related]
10. Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity. Biagioli M; Carino A Handb Exp Pharmacol; 2019; 256():95-108. PubMed ID: 31119464 [TBL] [Abstract][Full Text] [Related]
11. Bile Acids Activated Receptors Regulate Innate Immunity. Fiorucci S; Biagioli M; Zampella A; Distrutti E Front Immunol; 2018; 9():1853. PubMed ID: 30150987 [TBL] [Abstract][Full Text] [Related]
12. Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease. Marchianò S; Biagioli M; Bordoni M; Morretta E; Di Giorgio C; Vellecco V; Roselli R; Bellini R; Massa C; Cari L; Urbani G; Ricci P; Monti MC; Giordano A; Brancaleone V; Bucci M; Zampella A; Distrutti E; Cieri E; Cirino G; Fiorucci S J Am Heart Assoc; 2023 Dec; 12(23):e031241. PubMed ID: 37996988 [TBL] [Abstract][Full Text] [Related]
13. Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling. Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Morretta E; Monti MC; Distrutti E; Fiorucci S FASEB J; 2022 Jan; 36(1):e22060. PubMed ID: 34862975 [TBL] [Abstract][Full Text] [Related]
14. Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders. Fiorucci S; Sepe V; Biagioli M; Fiorillo B; Rapacciuolo P; Distrutti E; Zampella A Biochem Pharmacol; 2023 Oct; 216():115776. PubMed ID: 37659739 [TBL] [Abstract][Full Text] [Related]
15. 17β-Estradiol nongenomically induces vascular endothelial H Xu X; Yan Q; Liu X; Li P; Li X; Chen Y; Simoncini T; Liu J; Zhu D; Fu X J Biol Chem; 2019 Oct; 294(43):15577-15592. PubMed ID: 31439665 [TBL] [Abstract][Full Text] [Related]
16. The Pharmacology of Bile Acids and Their Receptors. Fiorucci S; Distrutti E Handb Exp Pharmacol; 2019; 256():3-18. PubMed ID: 31201555 [TBL] [Abstract][Full Text] [Related]
18. Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury. Biagioli M; Marchianò S; di Giorgio C; Roselli R; Bordoni M; Bellini R; Fiorillo B; Sepe V; Catalanotti B; Cassiano C; Monti MC; Distrutti E; Zampella A; Fiorucci S Hepatology; 2023 Jul; 78(1):26-44. PubMed ID: 36107019 [TBL] [Abstract][Full Text] [Related]
19. Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule. Hu Q; Wu D; Ma F; Yang S; Tan B; Xin H; Gu X; Chen X; Chen S; Mao Y; Zhu YZ Antioxid Redox Signal; 2016 Sep; 25(8):498-514. PubMed ID: 27174595 [TBL] [Abstract][Full Text] [Related]
20. Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis. Carino A; Marchianò S; Biagioli M; Bucci M; Vellecco V; Brancaleone V; Fiorucci C; Zampella A; Monti MC; Distrutti E; Fiorucci S FASEB J; 2019 Feb; 33(2):2809-2822. PubMed ID: 30303744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]